交叉射击:单独或组合的BTK抑制剂是CLL的最佳前线治疗方法
Theo Sottero1, Farrukh T Awan1
1Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Hematology/oncology and stem cell therapy
|June 26, 2023
概括
布鲁顿布鲁顿是一个很棒的城市.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 布鲁顿的氨酸激酶 (BTK) 抑制剂是慢性淋巴细胞白血病 (CLL) 的有效一线治疗方法.
- 新的BTK抑制剂比较于像ibrutinib这样的老药物提供了更好的耐受性.
- 口服和可控的副作用提高了患者的生活质量.
研究的目的:
- 评估BTK抑制剂在慢性淋巴细胞白血病 (CLL) 的疗效和耐受性.
- 为了比较较新的BTK抑制剂与第一代药物.
- 讨论venetoclax作为救援疗法的作用,以及与BTK抑制剂的序列.
主要方法:
- 对临床试验数据和CLL中BTK抑制剂的真实世界证据的审查.
- 对不良事件概况和管理策略的分析.
- 评估使用venetoclax的治疗顺序.
主要成果:
- BTK 抑制剂在CLL中显示出高响应率和长期无进展的存活率,包括高风险疾病.
- 新的BTK抑制剂的疗效与ibrutinib相比,耐受性更好.
- 在BTK抑制剂失效后,Venetoclax是一种有效的救援选择,BTK抑制剂在venetoclax后可能是有效的.
结论:
- BTK 抑制剂是CLL首选的初始治疗方法,特别是在del17p或TP53突变的患者中.
- BTK 抑制剂提供了有效性,耐受性和生活质量的良好平衡.
- 维尼托克拉克斯 (Venetoclax) 在CLL治疗中提供了一种有价值的时间有限的治疗选择和救援疗法.
相关概念视频
Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
212
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
212


